Pharma

Your Article Summary

See Latest Articles

Safer colchicine dosing regimen approved
American Pharmacists Association, 10/08/09

FDA has approved colchicine tablets with a much lower dosing regimen for gout flares compared with historic dosing. The approval was accompanied by warnings for potential serious and life–threatening drug interactions if colchicine is coadministered with P–glycoprotein or strong cytochrome P450 (CYP)3A4 inhibitors.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/08/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals